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A B S T R A C T
In subjects with multiple sclerosis (MS), pathology is more frequent near the inner and outer surfaces of the
brain. Here, we sought to explore if in subjects with primary progressive MS (PPMS) cortical lesion load is
selectively associated with the severity of periventricular normal appearing white matter (NAWM) damage, as
assessed with diﬀusion weighted imaging.
To this aim, twenty-four subjects with PPMS and twenty healthy controls were included in the study. Using
diﬀusion data, skeletonized mean diﬀusivity (MD) NAWM maps were computed excluding WM lesions and a
2 mm-thick peri-lesional rim. The supra-tentorial voxels between 2 and 6 mm of distance from the lateral
ventricles were included in the periventricular NAWM mask while the voxels between 6 and 10 mm from the
lateral ventricles were included in the deep NAWM mask; mean MD values were then computed separately for
these two masks. Lastly, cortical lesions were assessed on phase-sensitive inversion recovery (PSIR) images and
cortical thickness was quantiﬁed on volumetric T1 images.
Our main result was the observation in the PPMS group of a signiﬁcant correlation between periventricular
NAWM MD values and cortical lesion load, with a greater cortical lesion burden being associated with more
abnormal periventricular NAWM MD. Conversely, there was no correlation between cortical lesion load and
deep NAWM MD values or periventricular WM lesions.
Our data thus suggest that a common – and relatively selective - factor plays a role in the development of both
cortical lesion and periventricular NAWM abnormalities in PPMS.
1. Introduction
Although multiple sclerosis (MS) aﬀects the entire brain, lesions are
more extensive and extra-lesional pathology more intense in the white
matter (WM) and grey matter (GM) adjacent to the outer (i.e. subpial)
and inner (i.e. ventricular) surfaces of the brain (Brownell and Hughes,
1962; Pardini et al., 2016).
Cortical lesions, for example, are frequently found near the subpial
brain surface and are reported to be present in> 80% of subjects with
primary progressive MS (PPMS) (Choi et al., 2012). In all MS subtypes,
the presence of subpial cortical lesions has been linked with meningeal
inﬂammation, hinting a role for soluble inﬂammatory factors in mod-
ulating the spatial distribution of tissue damage. Moreover, while a
periventricular predilection for lesion formation has been recognised
for some time, (Adams et al., 1987) it has recently been shown in
subjects with relapse-onset MS that extra-lesional WM abnormalities
are also greater with proximity to the ventricles, even if the patholo-
gical bases of the latter observation are presently unknown (Brown
et al., 2017; Liu et al., 2015; Pardini et al., 2016).
Previous studies in subjects with relapse-onset MS have shown that
periventricular WM lesions are associated with the extent of cortical
atrophy (Jehna et al., 2015) and that a declining gradient of damage
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severity from the brain surface inwards is present both in deep and in
cortical GM, (Pardini et al., 2016) thus suggesting that a common factor
is involved in modulating cortical and periventricular pathology. Con-
versely, the association between tissue damage in these diﬀerent tissue
compartments in PPMS remains not characterized.
Here, given the wealth of information regarding cortical lesions
pathophysiology (Calabrese et al., 2010; Choi et al., 2012; Sethi et al.,
2013), we sought to explore the association, if any, between cortical
lesions and periventricular normal appearing (NA) WM abnormalities
as measured by (i) diﬀusion tensor imaging and (ii) periventricular WM
lesion volume in subjects with PPMS. Moreover, to better characterise
the relationship between cortical pathology and structural damage, we
also computed thickness of the cortical mantle.
2. Methods
2.1. Subject selection
Twenty-four subjects who met the modiﬁed McDonald diagnostic
criteria and were running a PPMS course were prospectively enrolled as
described elsewhere (Petracca et al., 2017). Twenty sex- and age-mat-
ched healthy subjects served as controls. Inclusion criteria for PPMS
patients were (i) age between 25 and 65 years, (ii) an Expanded Dis-
ability Status Scale (EDSS) equal or lower than 6.5 at screening visit,
and (iii) disease duration lower than 15 years. The use of immuno-
modulatory drugs was allowed but, if treated, patients had to be on
current treatment for at least 1 year. In the US it is not uncommon for
patients with PPMS to be tried on one of the approved im-
munomodulatory treatments despite the lack of Phase III clinical trials
evidence. Therefore, although our sample is not universally re-
presentative, it is representative of the US practice. Exclusion criteria
were (i) neuropsychiatric disorders other than MS, (ii) history of al-
cohol or drug abuse, and (iii) contraindications to MRI. Clinical and
demographical information are reported in Table 1.
2.2. MRI acquisition
MRI was performed using a 3.0 T scanner (Philips Achieva, The
Netherlands) with an 8-channel SENSE phased-array head coil (Philips
Achieva, The Netherlands) as previously described (Petracca et al.,
2017). The MRI protocol included the following sequences: (i) axial
dual echo/turbo spin echo sequence: repetition time (TR) = 2500 ms,
echo time (TE1) = 10 ms, TE2 = 80 ms, ﬁeld of view, FoV)
= 230 mm× 230 mm, matrix size = 512 × 512, 46 contiguous 3-
mm-thick slices; (ii) sagittal 3D T1-weighted turbo ﬁeld echo sequence:
TR/TE = 7.5/3.5 ms, inversion time (TI) = 900 ms, ﬂip angle = 8°,-
voxel-size = 1 × 1× 1 mm3, 172 contiguous slices; (iii) axial double
inversion recovery (DIR) sequence: TR/TE = 11,000/25 ms,
TI = 3400 ms; (iv) phase-sensitive inversion recovery (PSIR) sequence:
TR/TE/TI = 4500/8/400 ms and (v) single-shot EPI for diﬀusion
weighted imaging: TR/TE = 8550/89.5 ms b-values: 0,1000,2000 s/
mm2 32 non-collinear directions; voxel size 2 × 2 × 2 mm3. Both DIR
and PSIR were acquired with 46 contiguous 3-mm-thick slices with in-
plane reconstructed resolution of 0.5 mm× 0.5 mm.
2.3. MRI analysis
Cortical lesions were identiﬁed according to published criteria, on
PSIR images using DIR and T1 images as reference (Sethi et al., 2013). A
single observer blinded to clinical information and subject's identity,
under the supervision of a senior investigator performed all the lesion
loads. Intracortical (IC) lesions were deﬁned as lesions that were con-
ﬁned to the cortex, while lesions that involved both cortex and juxta-
cortical white matter (WM) were identiﬁed as leucocortical lesions
(LC). Juxtacortical lesions (JC) were diﬀerentiated from LC lesions
based on preservation of normal cortical contour and absence of cor-
tical involvement. Particular care was paid to exclude cortical vessels,
Virchow Robin spaces and artefacts. JC lesions, involving only WM,
were not included in further analysis, while LC and IC lesion volumes
were summed to quantify total cortical lesion volume. WM lesions were
identiﬁed on PD/T2 sequences and were then co-registered to diﬀusion
data using a linear transformation. All lesions were marked using Jim
version 6 (Xinapse Systems, Northants, England), using a semi-auto-
mated edge-ﬁnding tool based on local thresholding technique. FDT,
included in the FSL toolbox, was used to perform eddy-current cor-
rection on diﬀusion data and to ﬁt the diﬀusion tensor (Smith et al.,
2004). Mean diﬀusivity (MD) NAWM maps were created excluding WM
lesions and a 2 mm-thick peri-lesional rim as previously described (Liu
et al., 2015). Mean diﬀusivity (MD) NAWM maps were created ex-
cluding WM lesions ). Skeletonized NAWM MD maps, normalized to a
common space, were then computed using the TBSS pipeline (Smith
et al., 2006). In each skeletonized NAWM MD map, those supra-ten-
torial voxels with a distance from the lateral ventricles between 2 and
6 mm were included in the periventricular NAWM mask while those
voxels of skeletonized WM with a distance from the lateral ventricles
between 6 and 10 mm were included in the deep NAWM mask. Thus all
NAWM voxels with a distance from the ventricles> 10 mm were not
included neither in the periventricular NAWM mask nor in the deep
NAWM mask (Fig. 1). For these two regions, both mean MD and per-
centage of lesioned WM were computed. Moreover, whole brain nor-
malized grey matter (nGMV) volume and normalized brain volume
(nBV), were computed using Sienax (Smith et al., 2002) on lesion-ﬁlled
volumetric T1 images.
Lastly, cortical thickness was measured with the Freesurfer (version
v5.3.0) pipeline using lesion-ﬁlled volumetric T1 images. After
Freesurfer analysis, all images were reviewed by two experienced op-
erators.
2.4. Conﬁrmatory analysis: FA data
Using the same pipeline described above, we also computed mean
FA both in the skeletonized periventricular NAWM mask and the ske-
letonized periventricular NAWM mask. To take into account the re-
gional diﬀerences in WM architecture, which could impact on FA va-
lues, we used control data to convert raw FA values to z scores using the
following formula (FA_patient – mean_FA_control_group)/
standard_deviation_FA_control_group.
2.5. Conﬁrmatory analysis: Deep NAWM parcellation from the cortical
ribbon inward
Lastly, we decided to conﬁrm our ﬁndings using an alternative ap-
proach to create the deep NAWM mask, to try to accommodate for the
convoluted architecture of the cortex. Firstly, we computed the distance
from the cortical grey matter of all supratentorial voxels not previously
included in the periventricular mask, and then included in the deep
NAWMmask those voxels included in the farthest 4 mm from the cortex
(in line with the previous parcellation in 4 mm-wide regions).
Table 1
Clinical, demographic and conventional MRI data for the primary progressive multiple
sclerosis (PPMS) and healthy controls (HC) groups.
PPMS HC
Age (range, years) 50.8 (32–65) 51.1 (34–63)
Gender (M/F) 12/12 9/11
Disease duration (years) 9 ± 4.8 –
Median EDSS (range) 4 (1.5–6) –
Normalized brain volume (mL) 1368.5 ± 59.1 1434.1 ± 53.6
Normalized grey matter volume (mL) 721.8 ± 37.5 757.3 ± 39.0
White matter T2 lesion volume (mL) 5.9 ± 7.7 –
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2.6. Statistical analysis
Independent-samples t-tests and paired-sample t-tests were used to
compare NAWMMD values between PPMS subjects and controls and, in
the PPMS group, between periventricular and deep NAWM.
Associations between cortical lesion load and tissue abnormalities
were assessed with Pearson's correlations. Three subjects, for whom no
cortical lesions were reliably identiﬁed, were excluded from the main
correlation analyses only, however their inclusion in conﬁrmatory
analyses did not lead to signiﬁcant changes in the results. Conﬁrmatory
analyses correcting for whole brain WM lesion load, nBV and nGMV
were also performed using a partial correlations approach. Statistical
signiﬁcance was set at p < 0.05, uncorrected. However for all non-
conﬁrmatory analyses, we also computed pFDR-corrected values based
on the Benjamini–Hochberg methods. Statistical analysis was run with
SPSS software version 20.0 (SPSS Inc., Chicago, IL, USA).
2.7. Ethics
Written informed consent was obtained from all participants ac-
cording to the Declaration of Helsinki. The protocol was approved by
the Institutional Review Board of the Icahn School of Medicine at
Mount Sinai.
3. Results
3.1. Evaluation of periventricular NAWM abnormalities
Compared to controls, PPMS subjects had higher MD values in
periventricular (0.75 ± 0.06 mm3 / 10−3 vs 0.83 ± 0.09 mm3 /
10−3, p = 0.01, pFDR (corrected multiple comparisons) = 0.03) and
deep NAWM regions (0.73 ± 0.05 mm3 / 10−3 vs
0.77 ± 0.06 mm3 / 10−3, p = 0.01, pFDR (corrected multiple com-
parisons) = 0.03)). Moreover, in the PPMS group, MD values were
signiﬁcantly higher in periventricular than deep NAWM (t= 3.43,
p = 0.002, pFDR (corrected multiple comparisons) = 0.01)).
3.2. Association between periventricular abnormalities and cortical lesion
volume
A signiﬁcant, direct correlation was observed between periven-
tricular NAWM MD values and cortical lesion volume in the PPMS
group (r = 0.65 p = 0.001, pFDR (corrected multiple comparisons)<
0.01); Fig. 2-A), conversely there was no association between peri-
ventricular WM lesion load (percentage of lesioned WM: 5.3% ± 5.9)
and cortical lesion volume (r =−0.18, p = 0.43). Correction with
whole brain WM lesion load, nBV or nGMV did not signiﬁcantly alter
the results.
3.3. Association between deep white matter abnormalities and cortical
lesion volume
There was no association between deep NAWM MD values and
cortical lesion volume in the PPMS group (r = 0.14, p = 0.54, Fig. 2-
B), nor between deep WM lesion load and cortical lesion volume
Fig. 1. Periventricular (represented in light grey) and deep (represented in dark grey)
WM masks.
Fig. 2. Correlations between cortical lesion load and periventricular NAWM MD values
(panel A), and deep NAWM MD values (panel B). All data refer to primary progressive
multiple sclerosis (PPMS) subjects. PPMS subjects (n = 3) without clearly evident cortical
lesions were not included in these graphs.
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(r =−0.11, p = 0.59).
3.4. Association between periventricular and deep WM measures and
cortical thickness
There was no association between cortical thickness (mean thick-
ness 2,5 ± 0,3 mm) and periventricular or deep NAWM MD values in
the PPMS group (r =−0.17, p = 0.473, r =−0.04, p = 0.875).
Cortical thickness did not correlate with periventricular and deep WM
lesion load (r =−0.20, p = 0.320, r =−0.18, p = 0.379), or with
whole brain WM lesion load (r =−0.19, p = 0.363). Whole brain WM
lesion load correlated with cortical lesions (r = 0.52, p = 0.02, pFDR
(corrected multiple comparisons) = 0.06)), this correlation, however,
did not survive an FDR-correction for multiple comparison.
3.5. Conﬁrmatory analysis: FA
In the PPMS group z-scores converted FA data were signiﬁcantly
lower in the periventricular than deep NAWM (−0.97 ± 0.3 vs.
-0.79 ± 0.4, p = 0.003). The correlation between z-converted FA va-
lues and cortical lesion load was signiﬁcant taking into account peri-
ventricular NAWM (r =−0.56 p = 0.003), but not deep NAWM
(p = 0.43).
3.6. Conﬁrmatory analysis: Deep NAWM parcellation from the cortical
ribbon inward
Using the conﬁrmatory parcellation of deep NAWM, there was no
association between deep NAWM MD values and cortical lesion volume
(r = 0.16, p = 0.50), nor between deep WM lesion load and cortical
lesion volume (r =−0.14, p = 0.48).
4. Discussion
In this work, we showed that cortical lesions load was positively
associated with periventricular NAWM abnormalities, but not with
deep NAWM alterations nor with periventricular WM lesion load. These
ﬁndings suggest that, at least in PPMS, cortical lesions accrual could
share a common pathophysiological mechanism with periventricular
NAWM abnormalities development but not with WM lesion formation
or with deep NAWM alterations.
WM lesions nearly always form around veins and while some GM
lesions also appear to do so, subpial cortical GM lesions (the most
abundant type of GM lesion in progressive MS) do not follow the same
pattern (Bo et al., 2003), and have instead been linked with overlying
meningeal inﬂammation (Choi et al., 2012). The absence of a clear
association between cortical and WM lesion loads could be due to the
diﬀerent roles played by veins in cortical and WM lesions formation and
by the high density of veins in the periventricular region. This ﬁnding is
in line with previous work on relapse-onset MS (Pardini et al., 2016),
where it was showed that NAWM alterations, but not WM lesion den-
sity, were consistently inversely proportional to the distance from the
tissue/CSF boundary.
The pathological bases of gradients in periventricular NAWM ab-
normalities, observed in people with relapse-onset MS (Liu et al., 2015;
Pardini et al., 2016) and with clinically isolated syndrome (Brown
et al., 2017) is unknown, and speculation on possible mechanisms that
may link NAWM abnormalities and cortical lesions is therefore diﬃcult.
From an anatomical point of view, proximity of cortical lesions and
periventricular NAWM abnormalities to the surface of the brain raises
the possibility of a common factor surrounding the brain being relevant.
While meningeal inﬂammatory changes have been observed in MS, and
linked with demyelination and neuronal loss in underlying cortical GM,
(Bo et al., 2003; Choi et al., 2012) ependymal abnormalities described
as ‘granular ependymitis’ have only been seen in one study (Adams
et al., 1987). Proximity to CSF could also oﬀer a possible explanation
for our ﬁndings, as there is in vitro evidence that CSF in MS is neuro-
toxic (Vidaurre et al., 2014).
The lack of correlation between periventricular damage and cortical
thickness, on the other hand, is not in line with a previous study on
RRMS and CIS subjects, where an association between cortical thickness
and periventricular lesions was observed (Jehna et al., 2015). Com-
pared to the RRMS/CIS subjects, however, our patients probably pre-
sent with more marked structural alterations, together with a longer
disease duration. Moreover our patient group was smaller when com-
pared to the aforementioned RRMS/CIS study, even if probably less
heterogeneous. Future studies are needed to shed more light on the
possible diﬀerences in the association between cortical thickness and
white matter lesions across the diﬀerent disease subtypes.
To try to reduce partial volume eﬀects from CSF and WM lesions, we
excluded all WM voxels within 2 mm of the ventricles or WM lesions.
However, as periventricular NAWM abnormalities are more marked
close to the ventricles, it is likely that this will have reduced sensitivity
to periventricular NAWM abnormalities and lead us to underestimate
the strength of associations with cortical lesions. Moreover, to control
for a possible confounding eﬀect due to inter-subject diﬀerences in
ventricular volume, we used a non-linear registration to a common
space, included in the TBSS pipeline, and we veriﬁed that correcting for
nBV did not signiﬁcantly change the results.
Multiple correlations have been undertaken, and so it is possible
that some of the associations found may be spurious, however the
correlation between periventricular NAWM abnormalities and cortical
lesion load would survive a Bonferroni correction, if applied, and all
key results survive a FDR-correction for multiple comparisons. In ad-
dition, the moderate sample size counsels caution when seeking to
generalise the present ﬁndings, which however, are consistent with
recent observations in relapse onset MS.
In conclusion, our ﬁndings suggest that there is an association be-
tween cortical lesion load and periventricular NAWM abnormalities,
and so potentially a shared factor contributes to these two facets of MS
pathology in PPMS.
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